Evaluation of Ruthenium(II) N-Heterocyclic Carbene Complexes as Enzymatic Inhibitory Agents with Antioxidant, Antimicrobial, Antiparasitical and Antiproliferative Activity

Molecules. 2023 Jan 31;28(3):1359. doi: 10.3390/molecules28031359.

Abstract

A series of [RuCl2(p-cymene)(NHC)] complexes were obtained by reacting [RuCl2(p-cymene)]2 with in situ generated Ag-N-heterocyclic carbene (NHC) complexes. The structure of the obtained complexes was determined by the appropriate spectroscopy and elemental analysis. In addition, we evaluated the biological activities of these compounds as antienzymatic, antioxidant, antibacterial, anticancer, and antiparasitic agents. The results revealed that complexes 3b and 3d were the most potent inhibitors against AchE with IC50 values of 2.52 and 5.06 μM mL-1. Additionally, 3d proved very good antimicrobial activity against all examined microorganisms with IZ (inhibition zone) over 25 mm and MIC (minimum inhibitory concentration) < 4 µM. Additionally, the ligand 2a and its corresponding ruthenium (II) complex 3a had good cytotoxic activity against both cancer cells HCT-116 and HepG-2, with IC50 values of (7.76 and 11.76) and (4.12 and 9.21) μM mL-1, respectively. Evaluation of the antiparasitic activity of these complexes against Leishmania major promastigotes and Toxoplasma gondii showed that ruthenium complexes were more potent than the free ligand, with an IC50 values less than 1.5 μM mL-1. However, 3d was found the best one with SI (selectivity index) values greater than 5 so it seems to be the best candidate for antileishmanial drug discovery program, and much future research are recommended for mode of action and in vivo evaluation. In general, Ru-NHC complexes are the most effective against L. major promastigotes.

Keywords: 5,6-dimethylbenzimidazolium salts; HCT-116; HepG-2; Leishmania; N-Heterocyclic carbene; Toxoplasma; antimicrobial; antioxidant; enzyme inhibition; ruthenium.

MeSH terms

  • Anti-Infective Agents* / pharmacology
  • Antineoplastic Agents* / chemistry
  • Antineoplastic Agents* / pharmacology
  • Antioxidants / pharmacology
  • Coordination Complexes* / chemistry
  • Coordination Complexes* / pharmacology
  • Ligands
  • Ruthenium* / chemistry
  • Ruthenium* / pharmacology

Substances

  • Ruthenium
  • 4-cymene
  • Antioxidants
  • carbene
  • Ligands
  • Anti-Infective Agents
  • Antineoplastic Agents
  • Coordination Complexes

Grants and funding

The authors declare that no funds, grants, or other support were received during the preparation of this manuscript except the suppot for the project number (QU-IF-02-02-27782) from Deputyship for Research& Innovation, Ministry of Education, Saudi Arabia.